InterVest

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$101M
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

Biotech1
Healthtech1

By country

Netherlands1
United States1

Rounds

2 in this selection
Inocras

Whole-genome sequencing and bioinformatics platform for precision oncology

$31MSeries B
Role not disclosed
Vitestro

Develops autonomous robotic phlebotomy devices for diagnostic blood collection

$70MSeries B
Role not disclosed